These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11040067)

  • 1. Has GAD a central role in type 1 diabetes?
    Yoon JW; Sherwin RS; Kwon H; Jun HS
    J Autoimmun; 2000 Nov; 15(3):273-8. PubMed ID: 11040067
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoreactive T cells in human type 1 diabetes.
    Tree TI; Peakman M
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):113-33, ix-x. PubMed ID: 15053898
    [No Abstract]   [Full Text] [Related]  

  • 3. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 4. CD8+ suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65.
    James EA; Kwok WW
    Eur J Immunol; 2007 Jan; 37(1):78-86. PubMed ID: 17163450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S; Gauvrit A; Vu AT; Bach JM
    Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
    Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
    Lernmark A
    J Clin Invest; 2002 Apr; 109(7):869-70. PubMed ID: 11927613
    [No Abstract]   [Full Text] [Related]  

  • 8. Glutamic acid decarboxylase-specific CD4+ regulatory T cells.
    Liu CP
    Ann N Y Acad Sci; 2006 Oct; 1079():161-70. PubMed ID: 17130549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with GAD in diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition.
    Baekkeskov S; Aanstoot HJ; Fu Q; Jaffe M; Kim J; Quan J; Richter W; Shi Y
    Autoimmunity; 1993; 15 Suppl():24-6. PubMed ID: 7692998
    [No Abstract]   [Full Text] [Related]  

  • 11. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects.
    Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H
    J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus.
    Roep BO; Hiemstra HS; Schloot NC; De Vries RR; Chaudhuri A; Behan PO; Drijfhout JW
    Ann N Y Acad Sci; 2002 Apr; 958():163-5. PubMed ID: 12021098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of T cells in the pathogenesis of type I diabetes mellitus: structure analysis of complementarity determining region 3 of circulating T cells].
    Sakumai M; Yachie A; Kasahara Y
    Rinsho Byori; 2007 Feb; 55(2):112-9. PubMed ID: 17390713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large antigens such as GAD-65 become involved in pathogenic self-reactivity, but fortunately only rarely.
    Sercarz EE
    J Autoimmun; 2003 May; 20(3):203-6. PubMed ID: 12753804
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
    Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
    Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
    J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversations with GAD.
    Nepom GT
    J Autoimmun; 2003 May; 20(3):195-8. PubMed ID: 12753802
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.